Austin Neuromuscular Center

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Dermatomyositis and polymyositis (myositis)6 trials
• ALS (motor neurone disease)4 trials
• Myasthenia gravis2 trials
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
• Immune thrombocytopenia (ITP)1 trial

Phase

• Phase 25 trials
• Phase 2/34 trials
• Phase 32 trials
• Early phase 11 trial
• Phase 11 trial

Status

• Completed5 trials
• Recruiting4 trials
• Active, not recruiting3 trials
• Terminated1 trial

Lead sponsor

• Abcuro, Inc.2 trials
• Helixmith Co., Ltd.2 trials
• Janssen Research & Development, LLC2 trials
• Amgen1 trial
• argenx1 trial
• and 5 more

Running trials

• Recruiting

  A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

  NCT06987539· Phase 2· Amgen· Source

• Recruiting

  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  NCT07217587· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis

  NCT06450886· Phase 2/3· Abcuro, Inc.· Source

• Active, not recruiting

  A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

  NCT06643481· Phase 2· Novartis Pharmaceuticals· Source

• Recruiting

  Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  NCT06371417· Phase 1· Chugai Pharmaceutical· Source

• Recruiting

  Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

  NCT06479863· Early phase 1· Austin Neuromuscular Center· Source

  Contact: Emil Hussain, Manager

• Active, not recruiting

  Study to Learn If Tofersen (BIIB067) Can Delay ALS Symptoms and About Its Safety in Adults With a SOD1 Gene Mutation Who Have Not Yet Developed ALS Symptoms

  NCT04856982· Phase 3· Biogen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Dermatomyositis and polymyositis (myositis)2 recruiting
• Myasthenia gravis2 recruiting
• Immune thrombocytopenia (ITP)1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

  NCT05721573· Phase 2/3· Abcuro, Inc.· Source

• Terminated

  Study of M5049 in DM and PM Participants (NEPTUNIA)

  NCT05650567· Phase 2· EMD Serono Research & Development Institute, Inc.· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· Phase 2/3· argenx· Source

• Recruiting

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  NCT05327114· Phase 2/3· Janssen Research & Development, LLC· Source

• Completed

  A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis

  NCT05176093· Phase 2· Helixmith Co., Ltd.· Source

• Completed

  Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis

  NCT04632225· Phase 2· Helixmith Co., Ltd.· Source